Equillium, Inc. (EQ)
$1.32-12.00%Close
SELLCRISIS · day 23
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $47M
- Beta
- 1.92
- P/E (TTM)
- -5.15
- Short % float
- 31.58%
- Days to cover
- 6.0
- SI change
- +0.7%
- 1W
- -7.04%
- 1M
- -37.14%
- vs SPY 1W
- -6.90%
- vs SPY 1M
- -39.65%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on EQ?
- LOPJLB’s latest quantitative signal on Equillium, Inc. (EQ) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is EQ in?
- Equillium, Inc. (EQ) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Equillium, Inc. (EQ) do?
- Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune chec…